|
⚲
|
| Keyboard |
| Lange Louis G
✚
|
|
|---|---|
| CIK # | 0001238401 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001238401] | |
| 4 | [0001238401] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-11 | Sell | 446 | $31.23 | 13,929 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-11 | Sell | 44,173 | $30.41 | 1,343,301 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-09 | Option exercise | 44,619 | $11.50 | 513,118 |
|
NewAmsterdam Pharma Co NV NAMS
Warrant (right to buy) · derivative
|
2026-03-09 | Option exercise | 44,619 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-03-06 | Sell | 28,186 | $29.41 | 828,950 |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-07 | Grant | 3,400 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-01-07 | Grant | 15,300 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Restricted Stock Unit · derivative
|
2025-06-01 | Option exercise | 68 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-06-01 | Option exercise | 68 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Restricted Stock Unit · derivative
|
2025-05-01 | Option exercise | 69 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-05-01 | Option exercise | 69 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Restricted Stock Unit · derivative
|
2025-04-14 | Option exercise | 69 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-04-14 | Option exercise | 69 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-03-26 | Option exercise | 3,102 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Restricted Stock Unit · derivative
|
2025-03-26 | Grant | 3,308 | ||
|
NewAmsterdam Pharma Co NV NAMS
Restricted Stock Unit · derivative
|
2025-03-26 | Option exercise | 3,102 | ||
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-07 | Grant | 6,960 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2025-01-06 | Grant | 32,500 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2024-02-13 | Buy | 5,000 | $19.00 | 95,000 |
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2024-01-01 | Grant | 10,000 | $0.00 | |
| showing 20 of 127 most recent transactions | |||||